systemic mastocytosis
Jump to navigation
Jump to search
Introduction
Also see mastocytosis.
Pathology
- mast cell proliferation & organ infiltration
Clinical manifestations
- 1/2 of patients may have no skin findings
- weight loss
- weakness
- episodes of flushing (histamine release)
- headache
- diarrhea
- malabsoprion
- peptic ulcer
- bath pruritus (itching after hot bath)
- ascites
- osteopenia
Laboratory
Management
- treatment is primarily symptomatic with a goal of preventing mast cell activation[3]
- prevention & treatment of anaphylaxis
- pruritus & flushing
- diarrhea & intestinal malabsorption
- glucocorticoids to control malabsorption, bone pain, ascites, & to prvent anaphylaxis
- epinephrine for acute anaphylaxis
- histamine H1 receptor antagonists to control symptoms of anaphylaxis
- diphenhydramine, hydroxyzine
- aspirin may be useful if H1 blockers are not effective
- ketotifen (mast cell stabilizer)
- cromolyn is used for decreasing bone pain & headaches & for improving skin symptoms (flushing, pruritus)
- H2 receptor blockers or proton pump inhibitor for peptic ulcer
- psoralen ultraviolet A therapy for pruritus
- aticholinergics for diarrhea
- interferon alfa-2b may be useful in patients with osteopenia
More general terms
References
- ↑ Color Atlas & Synopsis of Clinical Dermatology, Common & Serious Diseases, 3rd ed, Fitzpatrick et al, McGraw Hill, NY, 1997, pg 718, 562-65
- ↑ Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 298
- ↑ 3.0 3.1 Krishnan K eMedicine (Medscape): Mastocytosis, Systemic http://emedicine.medscape.com/article/203948-overview
- ↑ Medical Knowledge Self Assessment Program (MKSAP) 19 American College of Physicians, Philadelphia 2022